Study genetics in inflammatory skin diseases involving neutrophils
Part of Blood & lymphatic, Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at genetic differences in people with certain inflammatory skin diseases that involve a specific type of immune cell (neutrophils). Your participation may help researchers better understand why these conditions happen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must sign a consent form to join the study
- You must have an eligible diagnosis in the “NMID” disease group
- If your samples were collected after 2014, you must have given consent for those samples
- If you are a healthy control, you must also sign consent to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new genetic causes of immune system conditions that can run in families. If you join, researchers will collect health information (and usually samples) from children with immune concerns and from close relatives for comparison.
This study looks at skin samples to better understand inflammatory skin diseases. By studying these samples, researchers hope to find new ways to diagnose and treat these conditions.
This study follows people with rare “autoinflammatory” conditions and sometimes their blood relatives to understand why symptoms happen and how they change over time. It may help by improving diagnosis and care for these conditions, using stored samples and genetic testing.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study collects and sequences (reads) your DNA to help researchers understand health and disease. You may be invited because you are connected to another NIH study, and you must agree to testing, sample storage, and sharing de-identified genetic data for future research.
This study looks at molecular (body-level) signatures in people with chronic inflammatory skin conditions. You may help researchers understand what drives inflammation, while receiving standard (already approved) systemic treatment through routine care.
Hear when a new Neutrophil-mediated Inflammatory Dermatoses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.